Why Novo Nordisk A/S (NVO) Stock Fell 2.7% on November 20, 2026
-2.70%$37.82November 20, 2026 · S&P 500 -3.64%
The short answer
Novo Nordisk A/S (NVO) stock is down 2.7% today, priced at 37.82, as part of a broader market decline, with the S&P 500 ETF (SPY) down 3.6% in the same session. This downward trend reflects a market-wide movement, impacting various stocks. Recent headlines mention that Novo Nordisk's Wegovy pill is capturing 80% of new oral obesity prescriptions, but it's unclear if this news directly influenced the stock's performance today. There is no single clear catalyst in the news for the decline.
The news behind it
Before you buy or sell
Get a second opinion on NVO
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when NVO moves
Price, RSI and volume alerts by email or push. Free plan →
Full market recap for November 20, 2026 · What's moving NVO today
Written from that session's quote and the headlines listed above. Educational, not financial advice.